Identification and validation of a 7-genes prognostic signature for adult acute myeloid leukemia based on aging-related genes
Figure 4. Different cell abundance of twenty-eight immune categories between HRPS-group/high-risk group and LRPS-group/low-risk group in training set (A) and validation set (B, C). (*P < 0.05, **P <0.01, ***P < 0.001).